Sort
15,440 grants matching “organoids”
Domesticating and Mapping Interactions of the Human Gastrointestinal Microbiome
$371,407Corey J. Wilson · Georgia Institute Of Technology · R35 · FY2025 · GM
Project 1: Effects of the Physical Microenvironment on Metabolism
$371,270Claudia Fischbach · Cornell University · U54 · FY2020 · CA
miR-145 target site blockade is a selective strategy to enhance CFTR restoration and readthrough
$371,250William Thomas Harris · University Of Alabama At Birmingham · R01 · FY2024 · HL
miR-145 target site blockade is a selective strategy to enhance CFTR restoration and readthrough
$371,250William Thomas Harris · University Of Alabama At Birmingham · R01 · FY2022 · HL
miR-145 target site blockade is a selective strategy to enhance CFTR restoration and readthrough
$371,250William Thomas Harris · University Of Alabama At Birmingham · R01 · FY2021 · HL
miR-145 target site blockade is a selective strategy to enhance CFTR restoration and readthrough
$371,250William Thomas Harris · University Of Alabama At Birmingham · R01 · FY2023 · HL
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
$371,216Ankur Singh · Cornell University · R33 · FY2017 · CA
Circadian Clock Disruption and Colorectal Cancer
$371,181Selma Masri · University Of California-Irvine · R01 · FY2024 · CA
Colonic responses to vitamin D and aspirin in African- and European-Americans
$371,169Sonia Kupfer · University Of Chicago · R01 · FY2021 · CA
Thyroid Follicular Cell Signaling and Development in Humans
$371,131Anthony N Hollenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Mechanisms of alcohol and menthol dependent pharmaco-neurological interactions with arecoline, an addictive and toxic areca (betel) nut xenobiotic
$371,129Alan L Myers · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DA
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$370,985Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$370,985Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
$370,939David J Beebe · University Of Wisconsin-Madison · P50 · FY2022 · CA
Mechanisms of female-biased autoimmunity in human immune organoids
$370,927Mark M Davis · Stanford University · U54 · FY2025 · AR
Regulation of mammary branching morphogenesis by Slit/Robo1 signaling
$370,908Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2011 · GM
Developmental Funds
$370,862Rafael Fonseca · Mayo Clinic Rochester · P30 · FY2020 · CA
Overcoming chemoresistance in triple negative breast cancer
$370,836Ozgur Sahin · Medical University Of South Carolina · R01 · FY2025 · CA
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
$370,830Ning Jenny Jiang · University Of Pennsylvania · R33 · FY2023 · CA
Quantitative Computational Methods to Accurately Measure Tumor Heterogeneity in Solid Tumors to Inform Development of Evolution-based Treatment Strategies
$370,786Jeffrey Hsu-Min Chuang · Jackson Laboratory · R01 · FY2021 · CA
Master regulator transcription factors promote esophageal neoplastic evolution
$370,711De-Chen Lin · University Of Southern California · R37 · FY2024 · CA
The Metabolic Regulation of Melanoma Metastasis
$370,699Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2019 · CA
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$370,628Xiaolin Zi · University Of California-Irvine · R01 · FY2022 · CA
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
$370,612Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2024 · CA
Investigating the molecular mechanisms of growth in GNAS mutant pancreatic cancer.
$370,575Krushna Chandra Patra · University Of Cincinnati · R37 · FY2025 · CA